Recursion Pharmaceuticals beat estimated earnings by 30.0%, reporting an EPS of $-0.21 versus an estimate of $-0.3. Revenue was up $30.99 million from the same period last year. During the previous ...
Based on the one-year price targets offered by 7 analysts, the average target price for Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is $7.00, with a high estimate of $11.00 and a low estimate of $3.00 ...
Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
Block said Thursday it's laying off more than 4,000 employees, or about half of its head count. Shares of the payment company skyrocketed as much as 24% in extended trading. It was last seen up nearly ...
Block, the company behind Square, Cash App and Afterpay, is cutting its staff by 40%. The reason: “intelligence tools,” according to a letter to shareholders by co-founder Jack Dorsey. Dorsey thinks ...
Jack Dorsey announced major layoffs at Block, cutting nearly half of its workforce. Dorsey said AI was behind the cuts, and the company's stock rose over 20% in after-hours trading. Tech and VC ...
This profile has not been claimed by the company. See reviews below to learn more or submit your own review. H&R Block is a tax preparation and financial services company that has been providing its ...
PayPal Holdings PYPL and Block XYZ stand out as key players in the fintech space. They continue to transform digital payments and commerce, albeit with distinct strategies: PayPal leverages its global ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. It’s taken more than 2,000 days of construction, $6.4 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results